Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis
Conditions
Interventions
- DRUG: fludarabine phosphate
- RADIATION: total-body irradiation
- DRUG: tacrolimus
- DRUG: mycophenolate mofetil
- BIOLOGICAL: rituximab
- DRUG: cyclophosphamide
- PROCEDURE: nonmyeloablative allogeneic hematopoietic stem cell transplantation
- PROCEDURE: peripheral blood stem cell transplantation
Sponsor
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Collaborators